Rheumnow Podcast

Listen as rheumatologist Dr. Kathryn Dao and
gastroenterologist Dr. Amar Naik share similarities and
differences in their clinical perspectives, including a
conversation on some of the benefits and risks of a JAKi in
each patient population.

Dr. Jack Cush reviews this past weeks news and journal reports from RheumNow.com.  Good news is that nearly 99% of adult rheumatology positions matched! But the challenge is that 45% of pediatric fellowship programs and 39% of pediatric rheum slots were unfilled in the 2024 NRMP match

In this weeks podcast, Dr. Jack Cush reviews the ACR Convergence 2023 meeting and proposes how to best learn at large medical meetings:

An Interview with Kevin Winthrop_ Three Questions About COVID 19
Assessment and Treatment of Cardiovascular Risks in Rheumatoid Arthritis
Biologics in RA_ Mechanisms of Delivery Over Mechanisms of Action_ (1)
Cannabinoid Receptor in RA Patients
Impact of Tofacitinib on Skeletal Muscle in RA
No Increased Mortality in Patients with RA Receiving Checkpoint Inhibitors
Non-TNFi b_tsDMARDs vs. TNFi in RA-ILD
Older RA Patients Just Aren't Getting Treated
People with RA and Long COVID Had Worse Pre-COVID RA Symptoms
Reproductive History, HPV Vaccination Among Women with SLE and  RA
Teledidactic vs On Campus Training in Musculoskeletal Ultrasound
The SMART Study_ Split Dose Oral Methotrexate
Unravelling the Mechanism of Clots with JAK Inhibitors
Upadacitinib for Pain_ Is That Real_
Will CAR T Cells also treat RA_

Another TYK2 Ticks the Boxes
Head to Head Comparison of Tofacitinib and TLL-018 in RA
Impact of Tofacitinib on Skeletal Muscle in RA
Is Point of Care Ultrasound Hocus Pocus_
JAK1 TYK2 in RA
Monitoring the Effect of Therapy with a...Smart Watch_
Non-TNFi b_tsDMARDs vs. TNFi in RA-ILD
Simulated JAK Trials to Counter ORAL Survelliance
Treatments in SpA
Unravelling the Mechanism of Clots with JAK Inhibitors
Upadacitinib for Pain_ Is That Real_

An Interview with Kevin Winthrop_ Three Questions About COVID 19
Does GnRHa Reduce Premature Ovarian Insufficiency in SLE Patients on Cyclophosphamide_
Identifying New Biomarkers in the Pathogenesis of SLE-PAH
Less (Glucocorticoids) is More in Lupus Nephritis
Lupus and the Patient Perspective
Lupus Nephritis Therapy Paradigm Shift
PR3+ in Lupus Nephritis
Racial and Ethnic Differences in Efficacy of Beliumumab in SLE
Reproductive History, HPV Vaccination Among Women with SLE and  RA
The Lupus APOL1 Story

Bimekizumab in Active AS_ 5 Year Study
Deep Neural Networks and Radiographic Progression in AxSpA
Difficult to Treat axSpA
From AS Patient to Rheumatologist
Imaging Updates in SpA
INVIGORATE-1 Study_ IV Secukinumab for Treatment of Active axSpA
Monitoring the Effect of Therapy with a...Smart Watch_
Overlap of Inflammatory and Degenerative Features in Radiographic axSpA
People with AxSpa Need More Sleep
Secukinumab vs. Adalimumab Biosimilar on Radiographic Progression in AxSpA
SpA Insights_ New Therapies
Teledidactic vs On Campus Training in Musculoskeletal Ultrasound
Treatments in SpA
Undiagnosed IBD in AxSpA
Using Telemedicine to Improve Diagnosis of AxSpA

Another TYK2 Ticks the Boxes
Correlation Between Patient and Physicians Assessments in PsA
Difficult to Treat axSpA
Effects of Apremilast on Cardiometabolic Effects in PsA
EHR Algorithms Identify PsA Patients
Is MSOT the New Ultrasound_
Is Point of Care Ultrasound Hocus Pocus_
SpA Insights_ New Therapies
Teledidactic vs On Campus Training in Musculoskeletal Ultrasound
The FOREMOST Study_ Apremilast in PsA
Ultrasound for PsA Stratification_ Are We There Yet_
Window of Opportunity in PsA

Join Drs. Jack Cush and Arthur Kavanaugh as they discuss highlights and key takeaways from ACR 23.

Join our live topic panel discussion!